APC |
antigen presenting cell |
BBB |
Blood–brain barrier |
BSCB |
Blood–spinal cord barrier |
CNS |
central nervous system |
CSF |
cerebrospinal fluid |
CXCL |
C-X-C chemokine ligand |
CXCR |
C-X-C chemokine receptor |
DC |
dendritic cell |
DMT |
disease-modifying treatment/therapy |
EAE |
experimental autoimmune encephalomyelitis |
ELR |
glutamic acid-leucine-arginine motif |
G-CSF |
granulocyte-colony stimulating factor |
GM-CSF |
granulocyte-macrophage colony-stimulating factor |
GPCR |
G-protein-coupled receptor |
HLA-DR |
human leukocyte antigen – DR isotype |
IgG |
immunoglobulin G |
IL |
interleukin |
IFN |
interferon |
LN |
lymph node |
MBP |
myelin basic protein |
MDM |
monocyte-derived macrophage |
MHC |
major histocompatibility complex |
MMP |
matrix metalloproteinase |
MOG |
myelin oligodendrocyte glycoprotein |
MPO |
Myeloperoxidase |
MRI |
magnetic resonance imaging |
MS |
multiple sclerosis |
NE |
neutrophil elastase |
NET |
neutrophil extracellular trap |
PAD |
protein arginine deiminase |
PLP |
proteolipid protein |
PPMS |
primary progressive multiple sclerosis |
REGA |
remnant epitope generates autoimmunity |
ROS |
reactive oxygen species |
RRMS |
relapsing-remitting multiple sclerosis |
SPMS |
secondary progressive multiple sclerosis |
TIMP |
tissue inhibitor of metalloproteinase |
TNF |
tumor necrosis factor |